Royal Bank of Canada’s Upstream Bio Inc UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-969
Closed -$26K 7837
2025
Q4
$26K Buy
969
+137
+16% +$3.41K ﹤0.01% 5907
2025
Q3
$16K Sell
832
-2,258
-73% -$35.1K ﹤0.01% 6330
2025
Q2
$33K Buy
3,090
+2,258
+271% +$20.9K ﹤0.01% 6094
2025
Q1
$5K Sell
832
-450
-35% -$4.3K ﹤0.01% 6382
2024
Q4
$21K Buy
+1,282
New +$28.6K ﹤0.01% 6099

Other funds holding UPB

Royal Bank of Canada's UPB Position: Q1 2026 in Review

Royal Bank of Canada sold out of Upstream Bio Inc (UPB) in Q1 2026, closing a stake of 969 shares — an estimated $26K sold.

Royal Bank of Canada first reported a position in UPB in Q4 2024 and held it in 5 quarters. The position peaked at $33K in Q2 2025. 140 funds tracked by Wall St. Rank hold UPB as of Q1 2026.

  • Royal Bank of Canada reported no remaining Upstream Bio Inc position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 969 Upstream Bio Inc shares in Q1 2026, an estimated $26K.
  • Royal Bank of Canada first reported a position in Upstream Bio Inc in Q4 2024 and held it in 5 quarters.
  • Royal Bank of Canada's Upstream Bio Inc position peaked at $33K in Q2 2025.
  • 140 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.